{"id":"W2565750033","doi":"10.1007/978-3-319-48066-4_15","title":"Promising Immunotherapeutic Approaches in Clinical Trials","year":2016,"lang":"en","type":"book-chapter","venue":"","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Monoclonal antibody; Nivolumab; Ipilimumab; Clinical trial; Immunotherapy; Cancer; Pembrolizumab; Chimeric antigen receptor; Antibody; Immunology; Melanoma; Cancer immunotherapy; Antigen; Oncology; Cancer research; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001749889,0.0007614118,0.0005521696,0.0007675607,0.0004055247,0.002399356,0.0007824133,0.001435777,0.03549881],"category_scores_gemma":[0.00141516,0.0003131683,0.000315237,0.0006089018,0.0008933112,0.002707245,0.001132372,0.003574483,0.01372969],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001116422,"about_ca_system_score_gemma":0.001246319,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003626573,"about_ca_topic_score_gemma":0.001317138,"domain_scores_codex":[0.9996477,0.0001144286,0.00001857767,0.00003412026,0.0001528394,0.00003224544],"domain_scores_gemma":[0.9996009,0.0002517595,0.00002018245,0.0000244295,0.00006254524,0.00004020789],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001179472,0.0001110587,0.00005344708,0.001053957,0.00001345362,0.0001640512,0.0001397321,0.0007712632,0.003836983,0.1124196,0.2840601,0.5972584],"study_design_scores_gemma":[0.00002116918,0.00003837402,0.00004015696,0.0003761293,0.000007171088,0.0002410077,0.00002369202,0.0001782076,0.000850047,0.02912639,0.9690911,0.000006568077],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001734211,0.5494148,0.03160578,0.02515556,0.01355275,0.0002416952,0.0005875342,0.0004697657,0.3772379],"genre_scores_gemma":[0.01428932,0.384137,0.02569711,0.020556,0.005245283,0.0004706439,0.0007375309,0.0004135821,0.5484534],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.03549881,"threshold_uncertainty_score":0.1187553,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.4995244382953016,"score_gpt":0.4734062569503706,"score_spread":0.02611818134493099,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}